# An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

> **NCT01077570** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 2033 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** repaglinide

## Key facts

- **NCT ID:** NCT01077570
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 2033 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01077570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01077570, "An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01077570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*